Literature DB >> 22356903

Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease.

Serena Bucossi1, Renato Polimanti, Stefania Mariani, Mariacarla Ventriglia, Cristian Bonvicini, Simone Migliore, Dario Manfellotto, Carlo Salustri, Fabrizio Vernieri, Paolo M Rossini, Rosanna Squitti.   

Abstract

Copper homeostasis appears abnormal in Alzheimer's disease (AD) patients. The aim of this study was to assess whether loci of susceptibility for AD lie in the Wilson's disease (WD) ATP7B gene. We studied single nucleotide polymorphisms (SNPs) K832R (c.2495 A>G, rs1061472) and R952K (c. 2855 G>A, rs732774) of the WD gene in 251 AD patients and 201 healthy controls. We also evaluated their relation with apolipoprotein E (ApoE) ε4 allele frequency. R allele in K832R [adjusted Odds Ratio (OR) = 1.71 (1.12-2.60); p = 0.012] and the K allele in R952K [adjusted OR = 1.82 (1.19-2.80); p = 0.006] ATP7B SNPs were associated with an increased risk of developing AD, as well as the haplotype R832/K952, containing the 2 risk alleles (X2 = 4.85; p = 0.028). Conversely, the K832/R952 haplotype appeared to confer protection against the disease (X2 = 7.21; p = 0.007). No difference in the frequency of the ATP7B alleles between carriers and non-carriers of the ApoE ε4 variant was revealed. The linkage disequilibrium (LD) analysis revealed an association between K832R and R952K substitutions in both AD patients (D' = 0.79) and controls (D' = 0.81). A high LD between K832R and R952K was also confirmed in all HapMap populations. Our investigation demonstrated the presence of loci of susceptibility for AD in the WD ATP7B gene, supporting a role of copper dysfunction in contributing or accelerating neurodegenerative processes leading to AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356903     DOI: 10.3233/JAD-2012-111997

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

1.  Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Authors:  Rosanna Squitti; Mariacarla Ventriglia; Massimo Gennarelli; Nicola A Colabufo; Imane Ghafir El Idrissi; Serena Bucossi; Stefania Mariani; Mauro Rongioletti; Orazio Zanetti; Chiara Congiu; Paolo M Rossini; Cristian Bonvicini
Journal:  Mol Neurobiol       Date:  2016-01-12       Impact factor: 5.590

2.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

Review 3.  Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease.

Authors:  Heng-Wei Hsu; Stephen C Bondy; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

4.  Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein.

Authors:  Courtney J McCann; Samuel Jayakanthan; Mariacristina Siotto; Nan Yang; Maria Osipova; Rosanna Squitti; Svetlana Lutsenko
Journal:  Metallomics       Date:  2019-06-19       Impact factor: 4.526

5.  In Vivo Modeling of the Pathogenic Effect of Copper Transporter Mutations That Cause Menkes and Wilson Diseases, Motor Neuropathy, and Susceptibility to Alzheimer's Disease.

Authors:  Stephen W Mercer; Jianbin Wang; Richard Burke
Journal:  J Biol Chem       Date:  2017-01-24       Impact factor: 5.157

Review 6.  Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Mst Marium Begum; Md Siddiqul Islam; Tapan Behl; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2020-08-21       Impact factor: 3.911

7.  ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease.

Authors:  Rosanna Squitti; Renato Polimanti; Mariacristina Siotto; Serena Bucossi; Mariacarla Ventriglia; Stefania Mariani; Fabrizio Vernieri; Federica Scrascia; Laura Trotta; Paolo Maria Rossini
Journal:  Neuromolecular Med       Date:  2013-06-13       Impact factor: 3.843

8.  Copper phenotype in Alzheimer's disease: dissecting the pathway.

Authors:  Rosanna Squitti; Renato Polimanti
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

9.  Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease.

Authors:  Rosanna Squitti; Renato Polimanti; Serena Bucossi; Mariacarla Ventriglia; Stefania Mariani; Dario Manfellotto; Fabrizio Vernieri; Emanuele Cassetta; Francesca Ursini; Paolo Maria Rossini
Journal:  Rejuvenation Res       Date:  2013-02       Impact factor: 4.663

Review 10.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.